Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

Study: New device helps people who lost vision due to blinding genetic disease

Research presented today at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common objects.

18 Nov 2013

Residents of major cities with high pollution levels have increased risk of dry eye syndrome

Residents of major cities with high levels of air pollution have an increased risk of dry eye syndrome, according to a study presented at the world's largest ophthalmic conference, the 117th Annual Meeting of the American Academy of Ophthalmology, in New Orleans.

17 Nov 2013

Cataract surgeries deliver 4,567% financial return on investment to society

Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study, published online today in the Academy's official journal, Ophthalmology, and will be presented on Nov. 17 at the world's largest ophthalmic conference, the American Academy of Ophthalmology's 117th Annual Meeting, in New Orleans. Researchers say that the results prove that healthcare interventions create substantial economic wealth.

16 Nov 2013

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (AREDS2) clinical centers, executed by the EMMES Corporation and sponsored by Notal Vision Ltd. Tel Aviv, Israel, have been accepted for publication in Ophthalmology.

16 Nov 2013

Oraya presents data from INTREPID study of stereotactic radiotherapy for treatment of wet AMD

Oraya® Therapeutics, Inc. announced today that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy™ stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time today during the America Academy of Ophthalmology's (AAO) annual meeting in New Orleans.

16 Nov 2013

Mass. Eye and Ear's OGSH launches new collaboration to care for people ENT diseases

Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.

16 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

High-power blue laser gadgets can cause serious eye damage

A type of high-power blue laser toy readily available over the Internet and increasingly popular among male teens and young adults can cause serious, sometimes irreversible, eye damage, according to a report by investigators from Saudi Arabia’s King Khaled Eye Specialist Hospital and Johns Hopkins Medicine.

14 Nov 2013

Hemianopia patients confirm prism benefits

Results from a crossover trial confirm anecdotal reports that patients with homonymous hemianopia benefit from wearing peripheral prism glasses.

13 Nov 2013

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.

13 Nov 2013

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the side where the visual field is missing.

12 Nov 2013

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.

11 Nov 2013

Children's Hospital Los Angeles opens new outpatient care center in Santa Monica

Children's Hospital Los Angeles opened the doors of its new outpatient care center in Santa Monica today. The pediatric medical facility, Children's Hospital Los Angeles - Santa Monica, will be staffed by 10 physicians who are Board-Certified in seven specialties and subspecialties, including hematology-oncology, medical genetics, neurology, orthopaedics, plastic and maxillofacial surgery, and urology.

8 Nov 2013

Study investigates association between preterm birth and later retinal detachment

Children born extremely prematurely have up to a 19 times greater risk of retinal detachment later in life than peers born at term, according to a Swedish study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology.

8 Nov 2013

Parent's use of digital photography shown as effective tool in diagnosis of retinoblastoma

Can parents use digital cameras and smart phones to potentially screen their children for the most common form of pediatric eye cancer? Baylor University and Harvard Medical School researchers believe so.

7 Nov 2013

NTU establishes new $60 million research institute in Nanomedicine

Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.

5 Nov 2013

New Dementia Service Center established as pilot project

In Germany, approximately 1.3 million people currently suffer from dementia. About 250,000 incident cases are estimated per year. Dementia is the leading cause of dependency and disability among older persons.

30 Oct 2013

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

If you've ever been sleep-deprived, you've probably had a firsthand glimpse of the blood vessels in your eyes. But what you haven't seen—and what many eye care professionals cannot see as well as they would like—are the vessels closest to the retina, the light-sensitive tissue at the back of the eye.

29 Oct 2013

Just 13 days in space may cause changes in eye structure, gene expression

Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.

25 Oct 2013

InnoCore, Allergan expand collaboration to develop ophthalmology medicines

InnoCore Pharmaceuticals today announced that it has signed an exclusive License and Collaboration Agreement with Allergan, Inc., a multi-specialty health care company headquartered in Irvine, California.

22 Oct 2013

Ophthalmology News and Research

Further Reading

Study: New device helps people who lost vision due to blinding genetic disease

Residents of major cities with high pollution levels have increased risk of dry eye syndrome

Cataract surgeries deliver 4,567% financial return on investment to society

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

Oraya presents data from INTREPID study of stereotactic radiotherapy for treatment of wet AMD

Mass. Eye and Ear's OGSH launches new collaboration to care for people ENT diseases

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

High-power blue laser gadgets can cause serious eye damage

Hemianopia patients confirm prism benefits

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

Children's Hospital Los Angeles opens new outpatient care center in Santa Monica

Study investigates association between preterm birth and later retinal detachment

Parent's use of digital photography shown as effective tool in diagnosis of retinoblastoma

NTU establishes new $60 million research institute in Nanomedicine

New Dementia Service Center established as pilot project

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

Just 13 days in space may cause changes in eye structure, gene expression

InnoCore, Allergan expand collaboration to develop ophthalmology medicines

Event guide: The 4th Ophthalmic Drug Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News